Cysteine 893 is a target of regulatory thiol modifications of GluA1 AMPA receptors

PLoS One. 2017 Feb 2;12(2):e0171489. doi: 10.1371/journal.pone.0171489. eCollection 2017.

Abstract

Recent studies indicate that glutamatergic signaling involves, and is regulated by, thiol modifying and redox-active compounds. In this study, we examined the role of a reactive cysteine residue, Cys-893, in the cytosolic C-terminal tail of GluA1 AMPA receptor as a potential regulatory target. Elimination of the thiol function by substitution of serine for Cys-893 led to increased steady-state expression level and strongly reduced interaction with SAP97, a major cytosolic interaction partner of GluA1 C-terminus. Moreover, we found that of the three cysteine residues in GluA1 C-terminal tail, Cys-893 is the predominant target for S-nitrosylation induced by exogenous nitric oxide donors in cultured cells and lysates. Co-precipitation experiments provided evidence for native association of SAP97 with neuronal nitric oxide synthase (nNOS) and for the potential coupling of Ca2+-permeable GluA1 receptors with nNOS via SAP97. Our results show that Cys-893 can serve as a molecular target for regulatory thiol modifications of GluA1 receptors, including the effects of nitric oxide.

MeSH terms

  • Adaptor Proteins, Signal Transducing / metabolism
  • Amino Acid Substitution
  • Catalytic Domain
  • Cysteine
  • Discs Large Homolog 1 Protein
  • HEK293 Cells / metabolism
  • Humans
  • Membrane Proteins / metabolism
  • Nitric Oxide Synthase Type I / metabolism
  • Receptors, AMPA / chemistry
  • Receptors, AMPA / metabolism*
  • Serine

Substances

  • Adaptor Proteins, Signal Transducing
  • DLG1 protein, human
  • Discs Large Homolog 1 Protein
  • Membrane Proteins
  • Receptors, AMPA
  • Serine
  • Nitric Oxide Synthase Type I
  • Cysteine
  • glutamate receptor ionotropic, AMPA 1

Grants and funding

This work was supported by The Magnus Ehrnrooth Foundation (LvO), The Alfred Kordelin Foundation (LL), and Orion Research Foundation (LL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.